BlackRock Health Sciences Opportunities Portfolio Class R
BHSRX
NASDAQ
| Weiss Ratings | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BlackRock | |||
| Manager/Tenure (Years) | Erin Xie (23), Xiang Liu (6) | |||
| Website | http://www.blackrock.com | |||
| Fund Information | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BlackRock Health Sciences Opportunities Portfolio Class R | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Sep 12, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 100.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.10% | |||
| Dividend | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.29% | |||
| Asset Allocation | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.16% | |||
| Stock | 98.36% | |||
| U.S. Stock | 95.29% | |||
| Non-U.S. Stock | 3.07% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.48% | |||
| Price History | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.73% | |||
| 30-Day Total Return | -3.79% | |||
| 60-Day Total Return | 3.56% | |||
| 90-Day Total Return | 0.57% | |||
| Year to Date Total Return | 7.84% | |||
| 1-Year Total Return | 16.54% | |||
| 2-Year Total Return | 15.48% | |||
| 3-Year Total Return | 38.22% | |||
| 5-Year Total Return | 32.46% | |||
| Price | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $60.14 | |||
| 1-Month Low NAV | $59.84 | |||
| 1-Month High NAV | $62.66 | |||
| 52-Week Low NAV | $57.51 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $66.77 | |||
| 52-Week High Price (Date) | Jul 07, 2026 | |||
| Beta / Standard Deviation | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.47 | |||
| Standard Deviation | 13.48 | |||
| Balance Sheet | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 6.26B | |||
| Operating Ratios | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.47% | |||
| Turnover Ratio | 49.00% | |||
| Performance | BHSRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 16.87% | |||
| Last Bear Market Total Return | -6.06% | |||